Nasenspray Kinder (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride, the active ingredient in Nasenspray Kinder, is an alpha‑adrenergic agonist presented as a nasal spray for nasal administration. It reduces swelling of the nasal mucosa, providing rapid relief of congestion caused by the common cold, sinusitis or allergic rhinitis in pediatric patients.

GNH USA supplies Nasenspray Kinder as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Xylometazoline Hydrochloride is a nasal decongestant that acts on the upper‑respiratory tract to relieve swelling. - Common cold: alleviates nasal congestion and improves breathing. - Sinusitis: reduces mucosal edema, facilitating sinus drainage. - Allergic rhinitis: diminishes nasal blockage caused by allergic inflammation.

Xylometazoline Hydrochloride may cause local or systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation: mild burning or stinging sensation. - Sneezing: transient increase in sneezing frequency. - Dryness: dryness of nasal mucosa. - Headache: mild headache.

Serious or Rare Side Effects: - Hypertension: elevated blood pressure in susceptible individuals. - Rebound congestion: worsening nasal blockage after prolonged use. - Cardiac arrhythmia: irregular heartbeat in rare cases. - Allergic reaction: rash, itching or swelling.

Use Nasenspray Kinder with caution and follow recommended guidelines. - Age restriction: not recommended for children under 2 years without medical advice. - Duration of use: limit to 3‑5 days to avoid rebound congestion. - Cardiovascular disease: use cautiously in patients with hypertension or heart disease. - Drug interactions: avoid concurrent use with monoamine oxidase inhibitors or other nasal decongestants. - Pregnancy and lactation: safety not established; consult a healthcare professional before use. - Store at room temperature: keep below 25 °C, protect from moisture and direct sunlight.

Xylometazoline Hydrochloride can interact with certain medications, affecting its safety or efficacy.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis. - Other nasal decongestants: increased risk of systemic vasoconstriction and rebound congestion.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: possible reduction in blood pressure control. - Tricyclic antidepressants: may enhance vasoconstrictive effects. - Beta‑blockers: potential additive cardiovascular effects.